Please provide your email address to receive an email when new articles are posted on . Once-monthly fitusiran prophylaxis improved outcomes compared with on-demand treatment for patients with severe ...
New FRONTIER5 results show a direct switch to investigational Mim8 (denecimig) prophylaxis treatment from emicizumab, without the need for a washout period, was well-tolerated in adults and ...
This is a video synopsis/summary of an Insights involving Allison Wheeler, MD. Wheeler addresses the nuanced considerations for implementing prophylaxis in patients with mild to moderate hemophilia A, ...
STOCKHOLM, July 9, 2019 /PRNewswire/ -- Clinical study data on switching haemophilia A and B patients from on-demand treatment to extended half-life (EHL) prophylaxis showed a positive impact on ...
Patients who received prophylactic concizumab had a mean overall annualized bleeding rate of zero compared with 9.8 among those who did not receive prophylactic therapy. 63.6% of patients in the ...
A recent follow-up to a 2007 study examined trends in prophylaxis treatment of hemarthrosis in a pediatric population with moderate-to-severe hemophilia A. Discharge codes were used to track bleeding ...
Prophylactic treatment with trimethoprim-sulfamethoxazole (TMP-SMX) significantly reduced the risk for serious infections by approximately 50% in patients with antineutrophil cytoplasmic antibody ...
Author(s)Hoffman V, Xue F, Ezzy SM, et al. Risk of cardiovascular, cerebrovascular events and mortality in patients with migraine receiving prophylactic treatments: an observational cohort study ...
Thrombosis occurs in more than 1 in 10 adults receiving PEGylated asparaginase (Asp)–based therapy for acute lymphoblastic leukemia (ALL), with a 4-fold ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback